Description of original award (Fiscal Year 2021, $1,399,678)
The first grant objective is to add a dedicated Business Analyst to support Integration efforts. The Business Analyst will work in concert with the Integration Developer, and existing Business Analyst to support KASPER integration and onboarding of integration institutional account partners. Integration efforts are complex and time consuming, however, considering the large amounts of data queried from Electronic Health Record (EHR) systems, its use is critical for patient care and clinical decision making. A study by the University of Michigan validates that querying KASPER reduces prescribing.
The second objective is to continue funding a criminal epidemiologist to enhance intelligence research and data analysis capacity within the KASPER team to support the Drug Enforcement and Professional Practices Branch. The criminal epidemiologist will design, manage, and conduct epidemiological studies to help reduce the incidence and prevalence of inappropriate controlled substance prescribing and dispensing. The criminal epidemiologist will assist local, state and federal law enforcement agencies with reviews of KASPER data and other public health data sources to quantify and visualize potentially inappropriate statewide controlled substance prescribing and dispensing.
The third grant objective is to create custom role dashboards within KASPER. Unique dashboards will be created for Drug Enforcement and Professional Practices Branch Staff, prescribers, and dispensers. These dashboards will allow prescribers to compare their prescribing habits of opioids, benzodiazepines, and stimulants to their respective peer groups. Dispensers will be able to view their ability to upload prescription data within regulated timeframes and monitor their response to error notification. Drug Enforcement and Professional Practices will have valuable data at their fingertips to address inappropriate prescribing or concerning trends.
The forth grant objective is to compare vital statistics death records, with KASPER prescribing data to notify prescribers of death by overdose of their patients with current opioid prescriptions. Prescribers will be notified either by letter, or by electronic means within KASPER. This should promote more thoughtful and educated prescribing techniques. After review, notifications may be forwarded to the appropriate medical licensure board(s).
The fifth, and final grant objective is to integrate KASPER with various licensure boards. Constructing data flow paths for KASPER registration and DEA number updates will allow for easier registration, and keep existing KASPER user accounts (including delegate accounts) up to date. Up to date KASPER account information is a critical component of both proper use, and statutory compliance.